Increased circulating thrombomodulin in children with septic shock

Critical Care Medicine

Volumn 26, Issue 5, 1998, Pages 933-938

  Krafte Jacobs, Brian ^a   Brilli, Richard ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Children; Critical illness; Endothelium; Multiple organ system failure; Septic shock; Thrombomodulin; Thrombosis

Indexed keywords

THROMBOMODULIN;

ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; INTENSIVE CARE; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEPTIC SHOCK;

ADOLESCENT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITAL MORTALITY; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVORS; THROMBOMODULIN;

EID: 0031945092     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199805000-00032     Document Type: Article

References (47)

1. Wilkinson JD, Pollack MM, Glass NL, et al: Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr 1987; 111:324-328
2. Voss R, Matthias FR, Borkowski G, et al: Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol 1990; 75:99-105
3. Lorente JA, Garcia-Frade LJ, Landin L, et al: Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 1993; 103:1536-42
4. Fourrier F, Chopin C, Goudemand J, et al: Septic shock, multiple organ failure, and disseminated intravascular coagulation. Chest 1992; 101:816-823
5. Rackow EC, Astiz ME: Pathophysiology and treatment of septic shock. JAMA 1991; 266:548-554
6. Takano S, Kimura S, Ohdama S, et al: Plasma thrombomodulin in health and diseases. Blood 1990; 10:2024-2029
7. Esmon CT: The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264:4743-4746
8. Lentz SR, Tsiang M, Sadler EJ: Regulation of thrombomodulin by tumor necrosis factor-α: Comparison of transcriptional and posttranscriptional mechanisms. Blood 1991; 542-550
9. Hirokawa K, Aoki N: Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro. J Cell Physiol 1991; 147:157-165
10. Boehme MWJ, Deng Y, Raeth U, et al: Release of thrombomodulin from endothelial cells by concerted action of TNF-α and neutrophils: In vivo and in vitro studies. Immunology 1996; 87:134-140
11. Boehme MWJ, Werle E, Kommerell B, et al: Serum levels of adhesion molecules and thrombomodulin as indicators of vascular injury in severe Plasmodium falciparum malaria. Clin Invest 1994; 72:598-603
12. Ishii H, Uchiyama H, Kazana M: Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991; 65:618-623
13. Abe H, Okajima K, Okabe H, et al: Granulocyte proteases and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro. J Lab Clin Med 1994; 123: 874-881
14. Boffa MC, Karnoshkine M, Berard M: Plasma thrombomodulin as a marker of endothelial damage. Nouv Rev Fr Hematol 1991; 33:529-530
15. Iba T, Yagi Y, Kidokoro A, et al: Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure. Surg Today 1995; 25:585-590
16. Boldt J, Muller M, Heyn S, et al: Influence of long-term continuous intravenous administration of pentoxifylline on endothelial-related coagulation in critically ill patients. Crit Care Med 1996; 24:940-946
17. Hayden WR: Sepsis terminology in pediatrics. J Pediatr 1994; 124:657-658
18. Pollack MM, Ruttimann UE, Getson PR: Pediatric risk of mortality (PRISM) score. Crit Care Med 1988; 16:1110-1116
19. Immubind® Thrombomodulin ELISA Kit product handbook. American Diagnostica, Greenwich CT, 1995
20. Esmon NL, Carroll RC, Esmon CT: Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem 1983; 258:12238-12242
21. Taylor FB, Chang A, Esmon CT, et al: Protein C prevents the coagulation and lethal effects of Escherichia coli infusion in the bahoon. J Clin Invest 1987; 79:918-925
22. Bajzar L, Nesheim ME, Tracy PB: The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood 1996; 88: 2093-2100
23. Weiler-Guettler H, Aird WC, Rayburn H, et al: Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos. Development 1996;122:2271-2281
24. Nawroth PP, Stern DM: Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163:740-745
25. Moore KL, Esmon CT, Esmon NL: Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 1989; 73:159-165
26. Redl H, Schlag G, Schieber A, et al: Thrombomodulin release in baboon sepsis: its dependence on the dose of Escherichia coli and the presence of tumor necrosis factor. J Infect Dis 1995; 171:1522-1527
27. Sawada K, Yamamoto H, Matsumoto K, et al: Changes in thrombomodulin level in plasma of endotoxin-infused rabbits. Thromb Res 1992; 65:199-209
28. Pigott R, Dillon LP, Hemingway IH, et al: Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatant of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun 1992; 187:584-589
29. Novick D, Engelmann H, Wallach D, et al: Soluble cytokine receptors are present in normal human urine. J Exp Med 1989;170:1409-1414
30. Asakura H, Jokaji H, Saito M, et al: Plasma levels of thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure. Am J Hematol 1991;38:281-287
31. Komai H, Haworth SG: Thrombomodulin and angiotensin-converting enzyme activity during pediatric open heart operations. Ann Thorac Surg 1996; 62:553-558
32. Boldt J, Knothe C, Welters I, et al: Normothermic versus hypothermic cardiopulmonary bypass: Do changes in coagulation differ? Ann Thorac Surg 1996; 62:130-135
33. Taniguchi Y, Yorioka N, Oda H, et al: Plasma thrombomodulin: usefulness as a blood access failure marker in hemodialysis patients. Nephron 1996; 73: 91-93
34. Rinno H, Kuramoto T, Iijima T, et al: Measurement of soluble thrombomodulin in sera from various clinical stages of diabetic nephropathy. J Clin Lab Anal 1996; 10:119-124
35. George F, Brouqui P, Boffa MC, et al: Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 1993; 82: 2109-2116
36. Takaya M, Ichikawa Y, Kobayashi N, et al: Serum thrombomodulin and anticardiolipin antibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1991; 9:495-499
37. Ford VA, Stringer C, Kennel SJ: Thrombomodulin is preferentially expressed in Balb/c lung microvessels. J Biol Chem 1992; 267:5446-5450
38. Wilkinson JD, Pollack MM, Ruttimann UE, et al: Outcome of pediatric patients with multiple organ system failure. Crit Care Med 1986; 14:271-274
39. Moore KL, Andreoli SP, Esmon NL, et al: Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987;79: 124-130
40. van Hinsbergh VWM, Kooistra T, van den Berg EA, et al: Tumor necrosis factor increases the productions of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 1988; 72:1467-1473
41. Fourrier F, Chopin C, Goudemand J, et al: Septic shock, multiple organ failure, and disseminated intravascular coagulation. Chest 1992; 101:816-823
42. Emerson TE, Fournal MA, Leach WJ, et al: Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat. Circ Shock 1987; 21:1-13
43. Solis MM, Cook C, Cook J, et al: Intravenous recombinant soluble human thrombomodulin prevents venous thrombosis in a rat model. J Vasc Surg 1991; 14:599-604
44. Ono M, Nawa K, Marumoto Y: Antithrombotic effects of recombinant human soluble thrombomodulin in a rat model of vascular shunt thrombosis. Thromb Haemost 1994; 72:421-425
45. Gonda Y, Hirata S, Saitoh K, et al: Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. Thromb Res 1993; 71:325-335
46. Hasegawa N, Kandra TG, Husari AW, et al: The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats. Am J Respir Crit Care Med 1996; 153:1831-1837
47. Aoki Y, Ohishi R, Takei R, et al: Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III. Thromb Haemost 1994; 71:452-455